Download | < Back |
02 Apr 2024 | |
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) and in accordance with the requirements of sub- clause 16(g) of Clause A of Part A of Schedule III of Listing Regulations, we wish to inform you that the Committee of Creditors ('CoC') of Parenteral Drugs (India) Limited 'the Corporate Debtor' in its 9th meeting approved the resolution plan of the Corporate Debtor. Further the resolution plan is being filed with NCLT Ahmedabad for approval | |
View all announcements for PARENTERAL DRUGS (INDIA) LTD. | Source: BSE India |